Financial Counselors Inc Penumbra Inc Transaction History

Financial Counselors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$181.44 - $260.22 $17,236 - $24,720	95 Added 11.45%	925 $232,000
Q3 2023 Nov 07, 2023	BUY	$240.69 - $338.77 $19,255 - $27,101	80 Added 10.67%	830 $200,000
Q2 2023 Jul 27, 2023	SELL	$271.54 - $344.06 $34,757 - $44,039	-128 Reduced 14.58%	750 $258,000
Q1 2023 May 02, 2023	BUY	$220.43 - $278.69 $193,537 - $244,689	878 New	878 $245,000
Q2 2022 Aug 02, 2022	SELL	$116.09 - $227.33 $110,285 - $215,963	-950 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$187.51 - $283.98 $28,126 - $42,597	150 Added 18.75%	950 $211,000
Q3 2021 Oct 26, 2021	SELL	$250.72 - $291.24 $12,536 - $14,562	-50 Reduced 5.88%	800 $213,000
Q2 2021 Aug 03, 2021	BUY	$235.0 - $310.7 $23,500 - $31,070	100 Added 13.33%	850 $233,000
Q1 2021 Apr 29, 2021	BUY	$175.6 - $291.43 $131,700 - $218,572	750 New	750 $203,000
Q2 2020 Aug 07, 2020	SELL	$153.32 - $191.72 $191,650 - $239,650	-1,250 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$124.34 - $193.76 $155,425 - $242,200	1,250 New	1,250 $202,000

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.